On the afternoon of January 7, 2022, a delegation of on-site promotion activities for the high-quality development of the county economy in the city visited Angtai for inspection and guidance. Xie Laifa, Secretary of the Municipal Party Committee, Yang Wenbin, Deputy Secretary of the Municipal Party Committee and Mayor, Jiang Wending, Deputy Secretary of the Municipal Party Committee, Liao Qizhi, Director of the Standing Committee of the Municipal People's Congress, and Zhan Yong, Chairman of the CPPCC Committee, and other leaders of the four sets of municipal teams, the "two chiefs" of the Municipal Legal Inspection, the counties (cities and districts) ) The main responsible comrades of the party committee and relevant departments directly under the municipality participated in the inspection activities. Wuning County Party Secretary Hong Bixia, Deputy Secretary and County Mayor Zhang Yufeng, Deputy County Party Secretary Liu Mingshou and other leaders accompanied.

Angtai Company fully relies on the company's own production technology advantages, actively integrates into the circle, expands capacity and upgrades. In 2021, Angtai Pharmaceutical Co., Ltd. and Guangzhou Laitai Pharmaceutical Co., Ltd. will invest 500 million yuan to jointly implement the Angtai large-scale health integration project, mainly engaged in seven earrings such as Hou Erhuan Anti-inflammatory Granules, Hou Erhuan Anti-inflammatory Capsules, Shuangdan Capsules and Shuangdan Tablets. The production and operation of a variety of traditional Chinese medicine, as well as the production and operation of plant hollow capsules. The project has completed the addition of 2 domestic first-class automatic Chinese medicine granule production lines, 5 sets of Chinese herbal medicine extraction with an annual processing capacity of more than 5,000 tons, and completed the upgrading of capsule and tablet production lines and the construction of sewage treatment facilities; at the same time, new plant hollow capsules have been built. 4 production lines. At present, 4 plant hollow capsule production lines have been officially put into production, and 2 granule drug production lines have been put into trial production. After the project is put into production, the annual output value will exceed 500 million yuan and the tax revenue will be 50 million yuan.

The delegation is optimistic about the development prospects of the Angtai big health integration project, encourages enterprises to seize new opportunities for the development of traditional Chinese medicine, further expand market share, strive for full production as soon as possible, and promote the high-quality development of the biopharmaceutical industry.